Popular Articles
Natural Remedies

New Data Proves Effectiveness Of Medtronic Insertable Cardiac Monitor In Detecting AF, Most Common Heart Rhythm Disorder
Atrial fibrillation (AF) is the most common arrhythmia, affecting an estimated 7 million people worldwide, including 4.5 million in the European Union1,2. Data presented today as a Hot Line session at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic, Inc. (NYSE: MDT), shows that the Medtronic Reveal® XT Insertable Cardiac Monitor (ICM) reliably identifies patients with AF (sensitivity of 96.1 percent) and correctly confirms the absence of AF in patients (negative predictive value of 97.4 percent).
generic viagra online
Test Detects Molecular Marker Of Aging In Humans
In 2004, researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center announced a crucial discovery in the understanding of cellular aging. They found that as cells and tissues age, the expression of a key protein, called p16INK4a, dramatically increases in most mammalian organs. Because p16INK4a is a tumor suppressor protein, cancer researchers are interested in its role in cellular aging and cancer prevention.
News of the day
GenWay Biotech Obtains Exclusive Rights To AMDL's DR-70 Cancer Test In US And Canada
GenWay Biotech, Inc., a US-based diagnostic company which specializes in providing protein and antibody solutions, announced its partnership with AMDL, Inc., a US-based pharmaceutical company with major operations in China, regarding the distribution of AMDL"s DR-70 (FDP) cancer test in both the United States and Canada. GenWay Biotech will be the exclusive distributor of the DR-70 test for general cancer screening by CLIA laboratories in the United States and for lung cancer screening in Canada. The commercialization efforts include raising awareness of the disease and demand creation for the test through multiple media channels and healthcare outreach. Both exclusive distribution agreements extend for five-years based on continuing success in both the Canadian and US markets.
Nutrition

Contur Software Adds Further Chemistry Tools To Web-Based ELN

Contur Software, a leading provider of electronic laboratory notebook (ELN) systems, announced added chemistry functionality in iLabber, the company"s recently launched high-end ELN system available as an online service. Using a software as a service (SaaS) model, Contur Software is making iLabber available to individual researchers and smaller R&D organizations that previously have not been able to utilize the advantages of high-end ELN systems due to investments in hardware, licenses and maintenance. The added functionality gives premium users of iLabber access to chemistry drawing, chemical structure and reaction searching, stoichiometric calculations (reaction planning), and iLabber"s inbuilt reagent and reactant databases. All chemistry searching in iLabber is powered by ChemAxon"s JChem Cartridge. In addition, ChemAxon"s MarvinSketch is provided to premium users at no extra cost. ChemAxon is a leading provider of chemical software development platforms for the biotechnology and pharmaceutical industries. "Because ChemAxon technology is well suited for the web the JChem Cartridge is a perfect fit for iLabber" said Alex Drijver, CEO at ChemAxon. "We see extensive possibilities for SaaS in cheminformatics and are happy to be involved in this pioneering project." Starting to use iLabber is easy and users simply download a desktop client. Operation, maintenance and data storage is securely managed by Contur Software. The service is available to individual researchers and smaller research groups (recommended up to 15 users). Individual researchers use iLabber for free, while there is a fee of 60 USD per month and user for commercial organizations. Academic institutions pay only half of that fee. "To smaller research groups with no IT support it is neither economical nor practical to purchase and maintain an in-house database system to gain access to an ELN and all these chemistry tools," said Martin Wattin, CEO at Contur Software. "The advantages of a web-based, yet high-end, ELN solution are indisputable and we have received compelling feedback from users." About Contur Software Contur Software is a privately owned software company founded in 1999. In 2003 the company launched ConturELN, an electronic laboratory notebook system that today is used by many leading organizations around the world. Customers are in the field of Pharma/Biotech, Chemicals and in academia. Contur Software is headquartered in Stockholm, Sweden. http://www.contur.com. ChemAxon


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):